Online investor platform now offers an Elite subscription plan along with API access and coverage of private biotechs
SAN DIEGO, May 18, 2023 /PRNewswire-PRWeb/ -- BioPharmCatalyst (BPC), a division of Scientist.com, announced today that it has expanded the suite of digital tools it provides biotech investors and other life science professionals. The company's new Elite plan gives users access to BPC's core services and a wide range of new features, including data on historical probabilities of clinical trial success, insider trading activities, mergers and acquisitions as well as a detailed biotech conference calendar. BPC now also provides data and analytics on private biotech companies not yet publicly traded. Larger users such as venture capitalists, growth equity investors and private equity investors can access most of this data through BPC's new Application Programming Interface (API), allowing seamless integration of BPC's rich data into their existing workflows.
"We're excited to unveil BioPharmCatalyst Elite in addition to access to our API, which provides our subscriber base with a wealth of new site features and easy access for businesses that want to integrate our data into their everyday processes," says Kris Kagan, SVP, BioPharmCatalyst. "Whether you are an institutional investor, a day trader looking to diversify your portfolio or a healthcare professional keeping tabs on the industry, our advanced biotech investing tools and resources will deliver significant value."
BPC provides indispensable tools to anyone interested in investing in the biotech industry. It helps investors make well-informed decisions based on the most recent corporate updates and clinical trial results. The newly released API facilitates real-time data retrieval from various endpoints, such as the FDA calendar, PDUFA calendar, Historical FDA calendar and Company & CEO screener.
BPC is currently offering a discounted Elite subscription rate as part of its Annual Sale. To register for a free or paid account, visit https://www.biopharmcatalyst.com/sign-up?source=landiing. For more information on API access, email [email protected].
About Scientist.com
BioPharmCatalyst is a division of Scientist.com, the biopharma industry's largest marketplace for R&D services. The company's digital research platform enables biopharma researchers to carry out more innovative experiments in less time and at lower cost. Scientist.com connects the world's top pharmaceutical companies, biotechnology companies and the US National Institutes of Health (NIH) to the world's largest network of scientific suppliers.
Media Contact
Sean Preci, Scientist.com, 858-815-9274, [email protected]
SOURCE Scientist.com
Share this article